Summit Therapeutics Inc. (Nasdaq: SMMT) today noted that its partner Akeso Inc. announced positive results from the Phase III ...
5hon MSN
Do you wake up at night to urinate? Here’s the number of times considered normal by experts
It’s something many experience without thinking twice: waking up in the dark to empty the bladder. In fact, nocturia affects ...
Spina bifida is a condition where there is a congenital abnormality in the formation of the spine or spinal ...
While UTIs are a common problem these days some people suffer from recurrent UTIs which can cause acute discomfort To ...
The letters could be extended to people who earn £200,000 or more a year or have assets worth above £2m, it is reported ...
The total number of BKVAN cases across the 7MM is expected to increase from approximately 4,000 cases in 2025, reflecting the growing kidney transplant population, continued exposure to ...
Georgia Lee Hampshire, 27, was taking up to 14g of a drug every day at the height of her 10-year addiction, suffering ...
"As a 38 year old mum of 2 who has struggled for years with stress incontinence due to childbirth. I have finally found my ...
Merck’s Keytruda plus Padcev receives European Commission approval to treat adults with resectable muscle-invasive bladder cancer: Rahway, New Jersey Friday, October 23, 2026, 1 ...
Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering precision immunotherapies for oncology and inflammation and immunology (I&I), today announced the presentation of Phase 2 ...
Learn about types of incontinence pads for MS, differences between bladder and menstrual pads, skin protection tips, insurance coverage, and when to seek medical help.
ERBB2-positive bladder cancer showed a 73.1% complete response rate with combination therapy in a phase II trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results